300 related articles for article (PubMed ID: 29966324)
1. The Use of Antidepressive Agents and Bone Mineral Density in Women: A Meta-Analysis.
Schweiger JU; Schweiger U; Hüppe M; Kahl KG; Greggersen W; Jauch-Chara K; Fassbinder E
Int J Environ Res Public Health; 2018 Jun; 15(7):. PubMed ID: 29966324
[TBL] [Abstract][Full Text] [Related]
2. Rates of bone loss among women initiating antidepressant medication use in midlife.
Diem SJ; Ruppert K; Cauley JA; Lian Y; Bromberger JT; Finkelstein JS; Greendale GA; Solomon DH
J Clin Endocrinol Metab; 2013 Nov; 98(11):4355-63. PubMed ID: 24001746
[TBL] [Abstract][Full Text] [Related]
3. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures.
Diem SJ; Blackwell TL; Stone KL; Yaffe K; Haney EM; Bliziotes MM; Ensrud KE
Arch Intern Med; 2007 Jun; 167(12):1240-5. PubMed ID: 17592096
[TBL] [Abstract][Full Text] [Related]
4. Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
Zhou C; Fang L; Chen Y; Zhong J; Wang H; Xie P
Osteoporos Int; 2018 Jun; 29(6):1243-1251. PubMed ID: 29435621
[TBL] [Abstract][Full Text] [Related]
5. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.
Haney EM; Chan BK; Diem SJ; Ensrud KE; Cauley JA; Barrett-Connor E; Orwoll E; Bliziotes MM;
Arch Intern Med; 2007 Jun; 167(12):1246-51. PubMed ID: 17592097
[TBL] [Abstract][Full Text] [Related]
6. Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study.
Feuer AJ; Demmer RT; Thai A; Vogiatzi MG
Bone; 2015 Sep; 78():28-33. PubMed ID: 25940460
[TBL] [Abstract][Full Text] [Related]
7. Bone density and depressive disorder: a meta-analysis.
Schweiger JU; Schweiger U; Hüppe M; Kahl KG; Greggersen W; Fassbinder E
Brain Behav; 2016 Aug; 6(8):e00489. PubMed ID: 27547495
[TBL] [Abstract][Full Text] [Related]
8. Bones of Contention: A Comprehensive Literature Review of Non-SSRI Antidepressant Use and Bone Health.
Power C; Duffy R; Mahon J; McCarroll K; Lawlor BA
J Geriatr Psychiatry Neurol; 2020 Nov; 33(6):340-352. PubMed ID: 31665962
[TBL] [Abstract][Full Text] [Related]
9. Association of mental disorders and psychotropic medications with bone texture as measured with trabecular bone score.
Hafizi S; Lix LM; Hans D; Bolton JM; Leslie WD
Bone; 2022 Dec; 165():116565. PubMed ID: 36152942
[TBL] [Abstract][Full Text] [Related]
10. Association of Selective Serotonin Reuptake Inhibitors and Bone Mineral Density in Elderly Women.
Saraykar S; John V; Cao B; Hnatow M; Ambrose CG; Rianon N
J Clin Densitom; 2018; 21(2):193-199. PubMed ID: 28712980
[TBL] [Abstract][Full Text] [Related]
11. Effects of antidepressants on postmenopausal bone loss - A 5-year longitudinal study from the OSTPRE cohort.
Rauma PH; Honkanen RJ; Williams LJ; Tuppurainen MT; Kröger HP; Koivumaa-Honkanen H
Bone; 2016 Aug; 89():25-31. PubMed ID: 27179631
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures.
Ziere G; Dieleman JP; van der Cammen TJ; Hofman A; Pols HA; Stricker BH
J Clin Psychopharmacol; 2008 Aug; 28(4):411-7. PubMed ID: 18626268
[TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
[TBL] [Abstract][Full Text] [Related]
14. Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients.
Arbouw ME; Movig KL; Neef C; Guchelaar HJ; Egberts TC
Eur J Clin Pharmacol; 2007 Feb; 63(2):181-7. PubMed ID: 17200834
[TBL] [Abstract][Full Text] [Related]
15. The adverse skeletal effects of selective serotonin reuptake inhibitors.
Tsapakis EM; Gamie Z; Tran GT; Adshead S; Lampard A; Mantalaris A; Tsiridis E
Eur Psychiatry; 2012 Apr; 27(3):156-69. PubMed ID: 21295451
[TBL] [Abstract][Full Text] [Related]
16. Does the use of SSRIs reduce medical care utilization and expenditures?
Chung S
J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density in adolescents with eating disorders exposed to selective serotonin reuptake inhibitors.
Couturier J; Sy A; Johnson N; Findlay S
Eat Disord; 2013; 21(3):238-48. PubMed ID: 23600554
[TBL] [Abstract][Full Text] [Related]
18. Weight outcomes among antidepressant users in nursing facilities.
Rigler SK; Webb MJ; Redford L; Brown EF; Zhou J; Wallace D
J Am Geriatr Soc; 2001 Jan; 49(1):49-55. PubMed ID: 11207842
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
[TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
Anderson IM
J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
